Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanna Scapin

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitorsScott D Edmondson, Anthony Mastracchio, Jason M Cox, et al.
Endocrinology, Diabetes & Metabolism|March 1, 2019
A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in miceJoel P Berger, Ranabir SinhaRoy, Alessandro Pocai, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
Discovery of potent, selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitorsJinyou Xu, Lan Wei, Robert J Mathvink, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2008
Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitorsScott D Edmondson, Lan Wei, Jinyou Xu, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2006
(3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesTesfaye Biftu, Dennis Feng, Xiaoxia Qian, et al.
Plos One|July 13, 2017
Antibacterial small molecules targeting the conserved TOPRIM domain of DNA gyraseScott S Walker, Marc Labroli, Ronald E Painter, et al.
Bioorganic & Medicinal Chemistry Letters|August 27, 2013
Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: Profile of clinical candidate (2R,3S,5R)-2- (2,5-difluorophenyl)-5-(4,6-dihydropyrrolo [3,4-c]pyrazol-5-(1H)-yl)tetrahydro-2H-pyran-3-amine (23) [corrected]Tesfaye Biftu, Xiaoxia Qian, Ping Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2014
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®Timothy A Blizzard, Helen Chen, Seongkon Kim, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2015
Structure-activity-relationship of amide and sulfonamide analogs of omarigliptinPing Chen, Dennis Feng, Xiaoxia Qian, et al.
Elife|May 30, 2018
Routine single particle CryoEM sample and grid characterization by tomographyAlex J Noble, Venkata P Dandey, Hui Wei, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitorsScott D Edmondson, Anthony Mastracchio, Jason M Cox, et al.
Endocrinology, Diabetes & Metabolism|March 1, 2019
A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in miceJoel P Berger, Ranabir SinhaRoy, Alessandro Pocai, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
Discovery of potent, selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitorsJinyou Xu, Lan Wei, Robert J Mathvink, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2008
Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitorsScott D Edmondson, Lan Wei, Jinyou Xu, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2006
(3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesTesfaye Biftu, Dennis Feng, Xiaoxia Qian, et al.
Plos One|July 13, 2017
Antibacterial small molecules targeting the conserved TOPRIM domain of DNA gyraseScott S Walker, Marc Labroli, Ronald E Painter, et al.
Bioorganic & Medicinal Chemistry Letters|August 27, 2013
Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: Profile of clinical candidate (2R,3S,5R)-2- (2,5-difluorophenyl)-5-(4,6-dihydropyrrolo [3,4-c]pyrazol-5-(1H)-yl)tetrahydro-2H-pyran-3-amine (23) [corrected]Tesfaye Biftu, Xiaoxia Qian, Ping Chen, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2014
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®Timothy A Blizzard, Helen Chen, Seongkon Kim, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2015
Structure-activity-relationship of amide and sulfonamide analogs of omarigliptinPing Chen, Dennis Feng, Xiaoxia Qian, et al.
Elife|May 30, 2018
Routine single particle CryoEM sample and grid characterization by tomographyAlex J Noble, Venkata P Dandey, Hui Wei, et al.
Pageof 7